Clinical trials recruiting in Hamm, Germany
9
Recruiting trials
10
Conditions
Phase breakdown
Phase 2 2Phase 3 3Not applicable 5
Conditions recruiting in Hamm, Germany
Recruiting trials in Hamm, Germany
- BAROSTIM THERAPY™ In Resistant Hypertension
- BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction
- Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis
- Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC
- NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
- NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer
- PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
- Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- The "Global Paradise System" Registry
Common questions
How many clinical trials are recruiting in Hamm, Germany?
9 recruiting trials have at least one study site in Hamm, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.